trending Market Intelligence /marketintelligence/en/news-insights/trending/_SslW3NIm4CrnzKEaX-Exg2 content esgSubNav
In This List

Ritter Pharmaceuticals falls out of Nasdaq compliance

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Ritter Pharmaceuticals falls out of Nasdaq compliance

Ritter Pharmaceuticals Inc. fell out of compliance with Nasdaq's $1 minimum bid price listing rule.

The Los Angeles-based developer of drugs to treat gastrointestinal diseases has until June 24, 2019, to regain compliance, with a possibility for extension.

The company plans to evaluate available options to address the deficiency and regain compliance with the rule, the company said in a filing.